Published in J Virol on February 01, 1991
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol (1993) 2.38
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol (1999) 1.66
Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol (1997) 1.64
Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J Virol (1994) 1.63
Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol (1995) 1.59
Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol (2009) 1.56
Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol (1993) 1.56
Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidase glycoprotein: effects on antigenic structure and function. J Virol (1994) 1.54
Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol (2011) 1.54
Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J Virol (1992) 1.53
Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol (1996) 1.44
Interacting domains of the HN and F proteins of newcastle disease virus. J Virol (2003) 1.39
Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci U S A (2012) 1.34
Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain. J Virol (1992) 1.23
Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J (2006) 1.21
The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18
Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces. J Virol (2002) 1.16
Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol (2014) 1.16
Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase. J Virol (1992) 1.15
Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability. J Virol (2013) 1.08
A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion. J Virol (2013) 1.07
Hemagglutinin-neuraminidase enhances F protein-mediated membrane fusion of reconstituted Sendai virus envelopes with cells. J Virol (1993) 1.05
Envelope protein dynamics in paramyxovirus entry. MBio (2013) 1.03
Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J Virol (2011) 0.96
Single event recording shows that docking onto receptor alters the kinetics of membrane fusion mediated by influenza hemagglutinin. Biophys J (1993) 0.93
gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment. J Virol (1994) 0.92
Unity in diversity: shared mechanism of entry among paramyxoviruses. Prog Mol Biol Transl Sci (2014) 0.88
A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus. J Virol (2005) 0.82
Disulfide bond formation is a determinant of glycosylation site usage in the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Virol (1997) 0.81
Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity. Can J Vet Res (1996) 0.80
Measles Virus Fusion Protein: Structure, Function and Inhibition. Viruses (2016) 0.78
Fusion between Newcastle disease virus and erythrocyte ghosts using octadecyl Rhodamine B fluorescence assay produces dequenching curves that fit the sum of two exponentials. Biochem J (1994) 0.77
Identification of an amino acid that defines the fusogenicity of mumps virus. J Virol (1993) 0.76
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol (1987) 6.88
Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol (1973) 5.64
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology (1977) 4.33
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A (1986) 4.14
Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci U S A (1969) 3.60
Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol (1988) 2.66
Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology (1987) 2.46
Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol (1980) 2.40
Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology (1984) 2.38
Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology (1983) 2.27
Mutation of a termination codon affects src initiation. Mol Cell Biol (1984) 2.23
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68
Intracellular processing of the Newcastle disease virus fusion glycoprotein. J Virol (1985) 1.65
Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology (1987) 1.52
Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol (1989) 1.50
Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences. Virus Res (1986) 1.46
HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Exp Cell Res (1982) 1.46
Identification of the P proteins and other disulfide-linked and phosphorylated proteins of Newcastle disease virus. J Virol (1981) 1.41
Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123. Virology (1987) 1.30
Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption. Proc Natl Acad Sci U S A (1987) 1.28
Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection. Virology (1989) 1.21
Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport. J Virol (1985) 1.08
The use of circular dichroism to study conformational changes induced in Sendai virus envelope glycoproteins. A correlation with the viral fusogenic activity. J Biol Chem (1986) 1.04
Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol (1988) 0.99
Fusion of a Sendai mutant deficient in HN protein (ts271) with cardiolipin liposomes. Virology (1988) 0.97
Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes. Virology (1984) 0.96
Construction of fusogenic vesicles bearing specific antibodies. Targeting of reconstituted Sendai virus envelopes towards neuraminidase-treated human erythrocytes. J Biol Chem (1984) 0.94
Glycoproteins of Sendai virus (HVJ) have a critical ratio for fusion between virus envelopes and cell membranes. Exp Cell Res (1982) 0.89
Estimation by radiation inactivation of the size of functional units governing Sendai and influenza virus fusion. Biochemistry (1987) 0.84
Preparation and characterization of F-protein vesicles isolated from Sendai virus by means of octyl glucoside. Biochim Biophys Acta (1986) 0.84
Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J Virol (1994) 1.63
The role of the amino terminus of F1 of the Newcastle disease virus fusion protein in cleavage and fusion. Virology (1993) 1.21
Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J Virol (2003) 1.14
The P protein and the nonstructural 38K and 29K proteins of Newcastle disease virus are derived from the same open reading frame. Virology (1988) 1.08
Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett (2001) 1.03
Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. Ther Drug Monit (1985) 1.00
Mature, cell-associated HN protein of Newcastle disease virus exists in two forms differentiated by posttranslational modifications. Virus Res (1990) 0.98
The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis (1997) 0.89
Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphoma. Ann Oncol (1999) 0.87
Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations. Int J Cancer (1999) 0.86
Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification. J Infect Dis (1999) 0.84
Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene (1996) 0.83
Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations. Leuk Lymphoma (1997) 0.83
Identification of the sequence content of four polycistronic transcripts synthesized in Newcastle disease virus infected cells. Virus Res (1986) 0.83
Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Oncogene (1999) 0.83
Role of a conserved sequence in the maturation and function of the NDV HN glycoprotein. Virus Res (1993) 0.82
Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Ann Hematol (1997) 0.82
Assembly of viral membranes. I. Association of vesicular stomatitis virus membrane proteins and membranes in a cell-free system. J Virol (1977) 0.80
Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription. Oncogene (1997) 0.78
Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a latent membrane protein-1 deletion variant. Transplantation (1997) 0.76
Epstein-Barr virus oncogenesis. Crit Rev Oncol Hematol (1997) 0.76
Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection. Int J Mol Med (1998) 0.76
Retroviral expressed hemagglutinin-neuraminidase protein protects chickens from Newcastle disease virus induced disease. Microb Pathog (1990) 0.75
Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy. Ann Hematol (1996) 0.75